Metcela Secures $12.7 Million Series B Financing to Initiate Phase I...

Metcela Inc., a clinical-stage biotech startup specializing in fibroblast-based cell therapy, announced the closing of its $12.7 million (1.3 billion yen) Series B round, led by The University of...(PRWeb January 03, 2021)Read the full story at https://www.prweb.com/releases/metcela_secures_12_7_million_series_b_financing_to_initiate_phase_i_clinical_trial_in_chronic_heart_failure_for_mtc001_cell_therapy/prweb17634410.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news